A detailed history of Aureus Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Aureus Asset Management, LLC holds 2,081 shares of AMGN stock, worth $612,916. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,081
Previous 2,111 1.42%
Holding current value
$612,916
Previous $659,000 1.67%
% of portfolio
0.04%
Previous 0.05%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $9,281 - $10,121
-30 Reduced 1.42%
2,081 $670,000
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $127,433 - $154,865
-485 Reduced 18.68%
2,111 $659,000
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $245,747 - $296,647
914 Added 54.34%
2,596 $738,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $22,245 - $25,096
87 Added 5.45%
1,682 $484,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $142,122 - $176,449
650 Added 68.78%
1,595 $428,000
Q2 2023

Aug 11, 2023

SELL
$214.27 - $253.37 $44,568 - $52,700
-208 Reduced 18.04%
945 $209,000
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $4,741 - $5,779
-21 Reduced 1.79%
1,153 $278,000
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $268,881 - $341,645
1,174 New
1,174 $308,000
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $227,941 - $253,659
-988 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $5,966 - $6,828
-30 Reduced 2.95%
988 $222,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $1.02 Million - $1.19 Million
-4,795 Reduced 82.49%
1,018 $216,000
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $629,030 - $697,864
-2,693 Reduced 31.66%
5,813 $1.42 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $823,064 - $959,147
-3,709 Reduced 30.36%
8,506 $2.12 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $899,058 - $1.07 Million
-4,155 Reduced 25.38%
12,215 $2.81 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $44,818 - $49,841
-191 Reduced 1.15%
16,370 $4.16 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $212,645 - $260,945
-1,075 Reduced 6.1%
16,561 $3.91 Million
Q1 2020

May 14, 2020

SELL
$182.24 - $241.7 $400,745 - $531,498
-2,199 Reduced 11.09%
17,636 $3.58 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $210,401 - $270,438
1,112 Added 5.94%
19,835 $4.78 Million
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $248,977 - $298,326
-1,430 Reduced 7.1%
18,723 $3.62 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $323,398 - $379,095
1,940 Added 10.65%
20,153 $3.71 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $30,747 - $34,659
-170 Reduced 0.92%
18,213 $3.46 Million
Q4 2018

Feb 13, 2019

SELL
$178.4 - $208.25 $45,670 - $53,312
-256 Reduced 1.37%
18,383 $3.58 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $370,580 - $417,780
-2,000 Reduced 9.69%
18,639 $3.86 Million
Q2 2018

Aug 13, 2018

SELL
$166.05 - $186.51 $146,124 - $164,128
-880 Reduced 4.09%
20,639 $3.81 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $216,870 - $253,440
-1,280 Reduced 5.61%
21,519 $3.67 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $69,203 - $77,321
410 Added 1.83%
22,799 $3.97 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $3.75 Million - $4.28 Million
22,389
22,389 $4.17 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aureus Asset Management, LLC Portfolio

Follow Aureus Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aureus Asset Management, LLC with notifications on news.